MedicalResearch.com Interview with:
[caption id="attachment_62111" align="alignleft" width="200"]
Prof. Trivedi[/caption]
Amal Trivedi, MD, MPH
Professor of Health Services, Policy & Practice
Brown University School of Public Health
MedicalResearch.com: What is the background for this study?
Response: On January 1
st, 2021, the Centers for Medicare & Medicaid Services (CMS) launched the mandatory End-Stage Renal Disease Treatment Choices (ETC) Model, which randomly assigned approximately 30% of U.S. dialysis facilities and managing clinicians to financial incentives to increase the use of home dialysis and kidney transplantation. The program is set to run through 2027, with financial incentives and penalties increasing as the model progresses.
Our study sought to assess the ETC’s effect on these outcomes of interest in the first two years, as well as to examine outcome changes by race, ethnicity and socioeconomic status.
